Mycophenolate mofetil with or without tracolimus (FK506) as a second line treatment for steroid-resistant acute graft-versus-host disease.: The experience of Saint Louis Hospital

被引：0
|
作者：
Fisher, G. [1 ]
Rocha, V. [1 ]
Dos Santos, M. [1 ]
Devergie, A. [1 ]
Robin, M. [1 ]
de Latour, R. Peffault [1 ]
Ribaud, P. [1 ]
Ferry, C. [1 ]
Gluckman, E. [1 ]
Socie, G. [1 ]
机构：
[1] Hop St Louis, Paris, France
来源：
BONE MARROW TRANSPLANTATION | 2007年 / 39卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S107 / S107
页数：1
相关论文
共 50 条
  • [21] Ileostomy for steroid-resistant acute graft-versus-host disease of the gastrointestinal tract
    Turki, Amin T.
    Bayraktar, Evren
    Basu, Oliver
    Benkoe, Tamas
    Yi, Ji-Hee
    Kehrmann, Jan
    Tzalavras, Asterios
    Liebregts, Tobias
    Beelen, Dietrich W.
    Steckel, Nina K.
    ANNALS OF HEMATOLOGY, 2019, 98 (10) : 2407 - 2419
  • [22] α1-Antitrypsin infusion for treatment of steroid-resistant acute graft-versus-host disease
    Magenau, John M.
    Goldstein, Steven C.
    Peltier, Dan
    Soiffer, Robert J.
    Braun, Thomas
    Pawarode, Attaphol
    Riwes, Mary M.
    Kennel, Maggi
    Antin, Joseph H.
    Cutler, Corey S.
    Ho, Vincent T.
    Alyea, Edwin P., III
    Parkin, Brian L.
    Yanik, Gregory A.
    Choi, Sung Won
    Lewis, Eli C.
    Dinarello, Charles A.
    Koreth, John
    Reddy, Pavan
    BLOOD, 2018, 131 (12) : 1372 - 1379
  • [23] Ileostomy for steroid-resistant acute graft-versus-host disease of the gastrointestinal tract
    Amin T. Turki
    Evren Bayraktar
    Oliver Basu
    Tamas Benkö
    Ji-Hee Yi
    Jan Kehrmann
    Asterios Tzalavras
    Tobias Liebregts
    Dietrich W. Beelen
    Nina K. Steckel
    Annals of Hematology, 2019, 98 : 2407 - 2419
  • [24] Novel approaches to the therapy of steroid-resistant acute graft-versus-host disease
    Antin, JH
    Chen, AR
    Couriel, DR
    Ho, VT
    Nash, RA
    Weisdorf, D
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2004, 10 (10) : 655 - 668
  • [25] Treatment of steroid-resistant acute graft-versus-host disease with anti-thymocyte globulin
    H Khoury
    A Kashyap
    DR Adkins
    RA Brown
    G Miller
    R Vij
    P Westervelt
    K Trinkaus
    LT Goodnough
    RJ Hayashi
    P Parker
    SJ Forman
    JF DiPersio
    Bone Marrow Transplantation, 2001, 27 : 1059 - 1064
  • [26] FK506 (Tacrolimus) in treatment of steroid resistant graft versus host disease in children post Bone Marrow Transplant
    Abd-Elghany, W
    Williams, M
    Lawson, S
    Darbyshire, PJ
    BONE MARROW TRANSPLANTATION, 1998, 21 : S120 - S120
  • [27] Mesenchymal stem cells for treatment of steroid-resistant graft-versus-host disease
    Ho, S. -J.
    Dyson, P.
    Rawling, T.
    Stevens, J.
    Patton, N.
    To, L. B.
    Lewis, I.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (02) : 46 - 47
  • [28] Treatment of steroid-resistant graft-versus-host disease with monoclonal antibodies in children
    Schechter, T.
    Afzal, S.
    Finkelstein, Y.
    Koren, G.
    Doyle, J.
    Dupuis, L. L.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (02) : 118 - 118
  • [29] Use of tacrolimus as salvage treatment in steroid-resistant graft versus host disease.
    Isola, L
    Chodoff, L
    Scigliano, E
    Vlachos, A
    Fruchtman, S
    BLOOD, 1996, 88 (10) : 3776 - 3776
  • [30] COMPARISON OF SIROLIMUS AND MYCOPHENOLATE MOFETIL AS SALVAGE TREATMENT FOR ACUTE GRAFT-VERSUS-HOST DISEASE
    Nishihori, T.
    Pidala, J.
    Kim, J.
    Tomblyn, M.
    Anasetti, C.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (02) : S368 - S368
12345